medigraphic.com
ISSN 1561-3127 (Electronic)
ISSN 0864-3466 (Print)

2019, Number 4

<< Back Next >>

Revista Cubana de Salud Pública 2019; 45 (4)

Trend and impact of mortality by cardiovascular diseases in Mexico, 1990-2015

Dávila CCA

Language: Spanish
References: 42
Page: 1-18
PDF size: 858.42 Kb.


ABSTRACT

Introduction: Cardiovascular diseases are the main causes of death´s group in Mexico.
Objective: To analyze trends of cardiovascular diseases in Mexico by sex, age, cause of death; and their impact in life expectancy from 1990 to 2015.
Methods: A descriptive study with information of vital statistics of mortality in Mexico. There were calculated standardized mortality rates by ischemic diseases, hypertensive diseases, cerebrovascular diseases, other heart conditions and other cardiovascular diseases. There were analysed the trends of the rates using a regression of segmented models; there were calculated the contributions to the change in life expectancy by cause and age.
Results: The trend of mortality by cardiovascular diseases presented three periods: between 1990 and 1997 there was an increase in both sexes; in 1997-2000 a decreasing trend; and between 2000-2015 a stationary trend in women and growing in men. The mortality due to ischemic heart disease and hypertensive diseases increased in men and women with consequent negative contribution to the life expectancy. On the contrary, cerebrovascular diseases decreased with gains in life expectancy. The other heart diseases tended to decrease by increasing life expectancy in both sexes.
Conclusions: In Mexico there is a decrease in mortality due to specific cardiovascular diseases with a positive contribution to the life expectancy in older adults; however, there are others that have a bearing in an increase in mortality, which decreases the life expectancy of the population, mainly for older adults.


REFERENCES

  1. Chen Y, Copeland W, Vedanthan R, Grant E, Lee J, Gu D, et al. Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium. BMJ 2013;347:f5446.

  2. Araujo R, Ochoa LA, López T. Determinantes sociodemográficos y muerte súbita cardiovascular. Revista Cubana de Salud Pública. 2015;41(3): 427-440.

  3. González JA, González JM. Factores de riesgo para la ocurrencia de infarto agudo del miocardio en pacientes fumadores. Rev Cub Sal Públ. 2013;39(4):679- 688.

  4. Lodoño E. Las enfermedades crónicas y la ineludible transformación de los sistemas de salud en América Latina. Rev Cub Sal Públ. 2017;43(1):1-6.

  5. Umbria M, Rafel J, Aluja MP, Santos C. Enfermedad cardiovascular en España: Estudio epidemiológico descriptivo 1999-2010. Antropo. 2014;32:1-13.

  6. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013; 380(9859):2095-128.

  7. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardio-metabolic risk factors between 1980 and 2010: comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2(8):634–647.

  8. World Health Organization (WHO). Global Atlas on cardiovascular disease prevention and control. Geneva: WHO; 2011

  9. Organización Panamericana de la Salud. Principales causas de muerte [Internet]. Washington DC: WHO; 2012. [acceso 23/07/2017]. Disponible en: http://www.paho.org/data/index.php/en/indicators-mortality/mnu-lcd-en.html.

  10. Fortune K, Salgado N, Cassanha LA, Murphy M. Los determinantes sociales de las enfermedades no transmisibles. En: Organización Panamericana de la Salud. Las dimensiones económicas de las enfermedades no transmisibles en América Latina y el Caribe. Washington, D.C.: OPS; 2017. p. 35-39.

  11. Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization [Internet]. Seattle, WA: IHME, University of Washington, 2016. [acceso 11/11/2017]. Disponible en: http://vizhub.healthdata.org/gbd-compare.

  12. Watkins D, Poggio R, Augustovski F, Brouwer E, Pichon A, Rubinstein A, et al. La costo-efectividad de las intervenciones y políticas para el control de las enfermedades no transmisibles y sus factores de riesgo en América Latina y el Caribe: revisión sistemática. En: Organización Panamericana de la Salud. Las dimensiones económicas de las enfermedades no transmisibles en América Latina y el Caribe. Washington, D.C.: OPS; 2017. p. 95-116.

  13. Hennis A. Prevención y control de las enfermedades no transmisibles en las Américas. En: Organización Panamericana de la Salud. Las dimensiones económicas de las enfermedades no transmisibles en América Latina y el Caribe. Washington, D.C.: OPS; 2017. p. 3-10.

  14. Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, et al. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;388(10058):2386-2402.

  15. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al.Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca: INSP; 2003.

  16. Hormigo Sánchez AI, González J, Jiménez Díaz G, Martín Sánchez FJ. Enfermedades cardiovasculares, respiratorias y renales. Medicine. 2014;11(62):3677-3690.

  17. Zahra A, Lee EW, Sun L, Park J. Cardiovascular disease and diabetes mortality, and their relation to socio-economical, environmental, and health behavioural factors in worldwide view. Public Health. 2015;129(4):385-395.

  18. Australian institute of health and welfare. Deaths [Internet]. Australia. [acceso: 23/07/2017]. Disponible en: http://www.aihw.gov.au/deaths/

  19. Mahapatra P, Shibuya K, Lopez AD, Coullare F, Notzon FC, Rao C, et al. Civil registration systems and vital statistics: successes and missed opportunities. Lancet. 2007;370(9599):1653-63.

  20. López-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. The Lancet Respiratory Medicine. 2014;2(1):54-62.

  21. Svihrova V, Barakov A, Szaboov V, Kamensky G, Hudeckova H. Trends in standardized mortality rates for select groups of cardiovascular diseases in Slovakia between 1980 and 2010. Public Health. 2016;130:43-50.

  22. Preston S, Heuveline P, Guillot M. Demography. Measuring and modeling population processes. Malden, MA: Blackwell Press, 2001.

  23. Andreev EM, Shkolnikov VM, Begun AZ. Algorithm for decomposition of differentials between aggregate demographic measures and its application to life expectancies, healthy life expectancies, parity progression ratios and total fertility rates. Demogr Res. 2002;7(14):499-522.

  24. Garcia JM. Contribuciones de la mortalidad cardiovascular a la esperanza de la población española de 1980 a 2009. Rev Esp Cardiol. 2013;66(11):848--853.

  25. Aguilar-Salinas CA, Mehta R, Rojas R, Gomez-Perez FJ, Olaiz G, Rull JA. Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: controversial issues. Curr Diab Rev. 2005;1:145-158.

  26. Leening MJG, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer DD, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014;349:g5992.

  27. Pérez-Hernández B, García-Esquinas E, Graciani A, Guallar-Castillón P, López-García E, León-Muñoz LM, et al. Desigualdades sociales en los factores deriesgo cardiovascular de los adultos mayores de España: estudio ENRICA-Seniors. Revista Española de Cardiología 2017;70(3):145-154.

  28. Córdova-Villalobos JA, Barriguete-Meléndez JA, Lara A, Barquera S, Rosas-Peralta M, Hernández-Ávila M, et al. Las enfermedades crónicas no transmisibles en México: sinopsis epidemiológica y prevención integral. Salud Publica Mex. 2008;50(5):419-427.

  29. World Health Organization (WHO). Global Health Estimates [Internet]. Ginebra: WHO; 2010 [acceso 23/07/2017]. Disponible en: http://www.who.int/healthinfo/global_burden_disease/en/

  30. Kaplan R, Avilés M, Parrinello CM, Hanna DB, Jung M, Castañeda SF, et al. Body Mass Index, Sex, and Cardiovascular Disease Risk Factors Among Hispanic/Latino Adults: Hispanic Community Health Study/Study of Latinos. J Am Heart Assoc. 2014;3:e000923.

  31. World Health Organization (WHO). Global health risks: Mortality and burden of disease attributable to selected major risks [Internet]. Geneva: WHO; 2009 [acceso 22/07/2017]. Disponible en: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf

  32. Tapia-Conyer R, Kuri-Morales P, Hoy-Gutiérrez MJ. Panorama epidemiológico del tabaquismo en México. Salud Publica Mex. 2001;43(5):478-484.

  33. Reynales-Shigematsu LM. Tobacco and cancer: epidemiology and new perspectives of prevention and monitoring in Mexico. Salud Publica Mex. 2016;58(2):251-260.

  34. Jose PO, Frank AT, Kapphahn KI, Goldstein BA, Eggleston K, Hastings KG, et al. Cardiovascular Disease Mortality in Asian Americans (2003-2010). J Am CollCardiol. 2014;64(23):2486-2494.

  35. Villalpando S, Shamah T, Rojas R, Aguilar CA. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006. Salud Publica Mex. 2010;52(s1):S72-S79.

  36. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016: Informe final de Resultados [Internet]. Cuernavaca: INSP; 2016 [acceso 21/07/2017]. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/209093/ENSANUT.pdf

  37. Orduñez PO, Cooper RS, Espinosa AD, Iraola MD, Bernal JL, La-Rosa Y. Enfermedades cardiovasculares en Cuba: determinantes para una epidemia y desafíos para la prevención y control. Rev Cubana Salud Pública. 2005;31(4):270-84.

  38. Bayauli PM, M’Buyamba-Kayamba JR, Lemogoum D, Thijs L, Dramaix M, Fagard R, et al. Prehypertension, Hypertension and Associated Cardiovascular Risk Factors among Adult Congolese Urban Dwellers: Results of the Vitaraa Study. World J CardiovascDis. 2014;4(8):390-398.

  39. Gutiérrez JP, García-Saisó S, Espinosa-de la Peña R, Balandrán DA. Desigualdad en indicadores de enfermedades crónicas y su atención en adultosen México: análisis de tres encuestas de salud. Salud Publica Mex. 2016;58(6):666-675.

  40. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010. Lancet. 2012;380(9859):2095-2128.

  41. González-Villalpando C, Dávila-Cervantes CA, Zamora-Macorra M, Trejo-Valdivia B, González-Villalpando ME. Incidence of type 2 diabetes in Mexico: Results of The Mexico City Diabetes Study after 18 years of follow-up. Salud Publica Mex. 2014;56(1):11-17.

  42. World Health Organization (WHO). Global Action Plan for the Prevention and Control of NCDs 2013-2020. Geneva: WHO; 2013.




2020     |     www.medigraphic.com